GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding GH Research PLC changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 36 | 38 | +2 |
| Shares | 42.6M | 43.6M | +934.8K (+2.2%) |
| Value | $470.1M | $530.9M | +$60.8M (+12.9%) |
New holders (7)
Institutions that held GH Research PLC at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 203,645 | $2.48M | 0.00% |
| StemPoint Capital LP | 100,826 | $1.23M | 0.40% |
| HighVista Strategies LLC | 52,247 | $636.9K | 0.23% |
| HighTower Advisors, LLC | 22,300 | $271.8K | 0.00% |
| Virtus Investment Advisers, Inc. | 7,329 | $89.3K | 0.03% |
| JPMorgan Chase & Co | 6,500 | $79.2K | 0.00% |
| Global Retirement Partners, LLC | 110 | $1.34K | 0.00% |
Sold out (5)
Institutions that held GH Research PLC at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 925,000 | $10.2M |
| Walleye Capital LLC | 52,940 | $583.9K |
| Citadel Advisors LLC | 15,586 | $171.9K |
| XTX Topco Ltd | 15,354 | $169.4K |
| Tortoise Investment Management, LLC | 1,781 | $19.6K |